Literature DB >> 25736515

Cumulative incidence of graft infection after primary prosthetic aortic reconstruction in the endovascular era.

P Berger1, I Vaartjes2, F L Moll3, G J De Borst3, J D Blankensteijn4, M L Bots2.   

Abstract

OBJECTIVE: The introduction of endovascular techniques has had a major impact on the case mix of patients that undergo open aortic reconstruction. Hypothetically, this may also have increased the incidence of aortic graft infection (AGI). The aim of this study was to report on the short and mid-term incidence of AGI after primary open prosthetic aortic reconstruction in the endovascular era.
METHODS: From 2000 to 2010, all 514 patients in a tertiary referral university hospital, undergoing primary open prosthetic aortic reconstruction for aneurysmal or occlusive aortic disease with at least one aortic anastomosis were included. Data were obtained by retrospectively analyzing the medical records, by contacting patients or their general practitioner by telephone, and by merging the dataset with the national Cause of Death Register. AGI was defined as proven by cultures or clinically in combination with positive imaging results. The 30 day, 1 year, and 2 year incidence rates were computed using life table analysis and expressed as percentages with 95% confidence intervals (CI).
RESULTS: AGI was diagnosed in 23 of the 514 included patients. 56% of the patients underwent elective surgery and 86% underwent surgery for an abdominal aortic aneurysm. The 30 day incidence was 1.6% (95% CI 0.4-2.8%), 1 year incidence was 3.6% (95% CI 1.7-5.5%), and 2 year incidence for AGI was 4.5% (95% CI 2.4-6.6%). The total number of person years (1058) yielded an AGI rate of 2.2 per 100 person years.
CONCLUSION: The 2 year cumulative incidence of AGI following primary, open aortic procedures with at least one aortic anastomosis is considerable, at around 1 in 20.
Copyright © 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aortic graft infection; Aortic reconstructions; Incidence

Mesh:

Year:  2015        PMID: 25736515     DOI: 10.1016/j.ejvs.2015.01.001

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

Review 1.  Treatment of Aortic Graft Infection in the Endovascular Era.

Authors:  Rebecca Sorber; Michael J Osgood; Christopher J Abularrage; James H Black; Ying Wei Lum
Journal:  Curr Infect Dis Rep       Date:  2017-09-19       Impact factor: 3.725

2.  Infections of the aorta.

Authors:  Chandrasekar Padmanabhan; Aayush Poddar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-05-10

3.  Hybrid Repair Combined with Fresh Arterial Allograft Extra-Anatomical Reconstruction: The Treatment of Infrarenal Abdominal Aneurysm above an Aortobifemoral Bypass Complicated by an Infected Pseudoaneurysm in the Left Groin.

Authors:  Robert Novotny; Tomas Marada; Jiri Novotny; Jakub Kristek; Jaroslav Chlupac; Michal Kudla; Kvetoslav Lipar; Jiri Mendl; Jiri Fronek; Libor Janousek
Journal:  Case Rep Vasc Med       Date:  2020-11-07

4.  Spondylodiscitis due to transmitted mycotic aortic aneurysm or infected grafts after endovascular aortic aneurysm repair (EVAR): A retrospective single-centre experience with short-term outcomes.

Authors:  Nicolas Heinz von der Höh; Philipp Pieroh; Jeanette Henkelmann; Daniela Branzan; Anna Völker; Dina Wiersbicki; Christoph-Eckhard Heyde
Journal:  Eur Spine J       Date:  2020-09-07       Impact factor: 3.134

5.  Influence of the new standardized clinical cryopreservation/slow thawing protocol on immunogenicity of arterial allografts in rats.

Authors:  Jan Hruby; Rudolf Spunda; Pavel Mericka; Mikulas Mlcek; Ondrej Pecha; Katrin Splith; Moritz Schmelzle; Felix Krenzien; Jaroslav Lindner; Miroslav Spacek; Ivan Matia
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

6.  Early experience and technical aspects of physician-modified fenestration in thoracic endovascular aortic repair for aortic arch pathologies.

Authors:  Xin Li; Quanming Li; Weichang Zhang; Ming Li; Hao He; Mingyao Luo; Kun Fang; Chenzi Yang; Jieting Zhu; Chang Shu
Journal:  J Int Med Res       Date:  2019-09-23       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.